NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

BIO | NYSE

$355.57 -$22.14 | -5.86%
SIGNAL:Signal available — unlock to view |2026-09-08 |F&G 45 |RSI 36.7

Company Overview:

Market Cap: $9.68B
Trailing PE: 43.1x
FWD PE *: 34.5x
Payout Ratio (TTM): —
52-Week Range: $236.73 - $396.23

* Forward PE is based on street estimates.

10 Year BIO Performance Metrics:

Total Return (with DRIP): 117.2% (8.06% CAGR)
Total Return (no DRIP): 117.2% (8.06% CAGR)
Share Price: 117.1% (8.06% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $21,717
Total Return $ (with DRIP): $11,717
BIO Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
BIO Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

BIO Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

BIO - Revenue
BIO Revenue CAGR:1Y: -0.09%2Y: 0.98%5Y: -1.88%10Y: 2.34%
BIO - Earnings Per Share (EPS)
BIO EPS CAGR:1Y: 18.68%2Y: 0.00%5Y: -14.50%10Y: 36.65%
BIO - Net Income
🔓 See the full chart40% off right now · 7-day free trial
BIO Net Income CAGR:1Y: 16.87%2Y: 0.00%5Y: -16.48%10Y: 35.34%
BIO - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
BIO EBITDA CAGR:1Y: 13.60%2Y: 0.00%5Y: 27.91%10Y: 22.49%
BIO - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
BIO Free Cash Flow CAGR:1Y: -5.79%2Y: 9.76%5Y: -12.66%10Y: 3.88%
BIO - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
BIO Free Cash Flow / Share CAGR:1Y: -4.10%2Y: 13.09%5Y: -10.77%10Y: 4.87%
BIO - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
BIO Operating Income CAGR:1Y: -5.84%2Y: -15.42%5Y: -10.27%10Y: 12.42%
BIO - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
BIO Gross Profit CAGR:1Y: 0.14%2Y: -1.32%5Y: -2.95%10Y: 2.12%
BIO - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
BIO Shares Outstanding CAGR:1Y: -1.52%2Y: -2.82%5Y: -2.32%10Y: -0.98%
BIO - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
BIO Share Buybacks CAGR:1Y: -77.53%2Y: -44.15%5Y: 128.38%10Y: 0.00%
BIO - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
BIO Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BIO - Expenses
🔓 See the full chart40% off right now · 7-day free trial
BIO Expenses CAGR:1Y: -29.98%2Y: -13.00%5Y: 6.47%10Y: 0.13%
BIO - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
BIO - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
BIO - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
BIO - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
BIO - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
BIO - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
BIO - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
BIO Revenue CAGR:1Y: -0.09%2Y: 0.98%5Y: -1.88%10Y: 2.34%
BIO - Revenue by Region
🔓 See the full chart40% off right now · 7-day free trial
BIO Revenue CAGR:1Y: -0.09%2Y: 0.98%5Y: -1.88%10Y: 2.34%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

BIO - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
BIO Actual Revenue CAGR:1Y: -0.09%2Y: 0.98%5Y: -1.88%10Y: 2.34%
BIO - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
BIO Actual EPS CAGR:1Y: 18.68%2Y: 0.00%5Y: -14.50%10Y: 36.65%
BIO - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
BIO Actual Net Income CAGR:1Y: 16.87%2Y: 0.00%5Y: -16.48%10Y: 35.34%
BIO - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
BIO Actual EBITDA CAGR:1Y: 13.60%2Y: 0.00%5Y: 27.91%10Y: 22.49%

Ratios, Profit Margins & Return on Capital:

BIO - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
BIO Net Profit Margin CAGR:1Y: 16.98%2Y: 0.00%5Y: -14.88%10Y: 32.23%
BIO - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
BIO Gross Profit Margin CAGR:1Y: 0.25%2Y: -2.35%5Y: -1.08%10Y: -0.21%
BIO - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
BIO Price to Earnings CAGR:1Y: 2.22%2Y: 0.00%5Y: 0.15%10Y: -21.35%
BIO - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
BIO Price To Sales Ratio CAGR:1Y: 19.63%2Y: 1.37%5Y: -14.75%10Y: 4.02%
BIO - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
BIO Return on Capital Employed CAGR:1Y: -2.04%2Y: -15.33%5Y: -1.87%10Y: 1.86%
BIO - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
BIO Return on Invested Capital CAGR:1Y: -15.83%2Y: -21.99%5Y: -9.59%10Y: 0.35%

Compare stocks side-by-side

Projected Future Returns & Dividends for BIO

Based on past 10-year performance, here are BIO growth metrics:

Share price CAGR of +8.06%
Dividend CAGR of +0%

Using BIO CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

BIO (DRIP)BIO - No DRIP
Current Price$355.57$355.57
Start Shares28.1228.12
Start Value$10,000$10,000
  
After 10 years:
Final Share Count28.1228.12
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$355.57$355.57
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - BIO

NOTE: Above numbers are our estimate based on BIO's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

Company Info

Bio-Rad Laboratories, Inc. (BIO) had its IPO on 1980-02-27, and is traded on NYSE stock exchange.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

BIO website: https://www.bio-rad.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)
Loading signals…

DCF Model — BIO

Value from:
Pay up to today
—
vs current price $355.57
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →